Your browser doesn't support javascript.
loading
Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial.
Crabb, Simon J; Griffiths, Gareth; Dunkley, Denise; Downs, Nichola; Ellis, Mary; Radford, Mike; Light, Michelle; Northey, Josh; Whitehead, Amy; Wilding, Sam; Birtle, Alison J; Khoo, Vincent; Jones, Robert J.
Afiliação
  • Crabb SJ; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK. Electronic address: s.j.crabb@southampton.ac.uk.
  • Griffiths G; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Dunkley D; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Downs N; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Ellis M; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Radford M; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Light M; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Northey J; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Whitehead A; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Wilding S; Southampton Clinical Trials Unit, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Birtle AJ; Lancashire Teaching Hospitals NHS Foundation Trust, University of Central Lancashire and University of Manchester, Preston, UK.
  • Khoo V; The Royal Marsden NHS Foundation Trust, London, UK.
  • Jones RJ; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK.
Eur Urol ; 82(5): 512-515, 2022 11.
Article em En | MEDLINE | ID: mdl-35688662
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2022 Tipo de documento: Article